Literature DB >> 31032095

Comparison of tumor regression grading system in locally advanced esophageal squamous cell carcinoma after preoperative radio-chemotherapy to determine the most accurate system predicting prognosis.

Nathawadee Lerttanatum1, Chadin Tharavej2, Yuda Chongpison3, Anapat Sanpavat1.   

Abstract

BACKGROUND: Nowadays, preoperative radio-chemotherapy is a standard treatment for locally advanced esophageal squamous cell carcinoma (ESCC). Tumor regression grade (TRG), referring to a classification of cancer response to preoperative treatment, can predict a prognosis of survival. Many TRG systems are proposed for use in esophageal cancer, but none of them has become standard grading system. This research compared five TRG systems, including Mandard system, Chirieac system, Schneider system, Hermann system, and Japan Esophageal Society (JES) system, to find the most accurately predictive system.
METHODS: We recruited 37 participants with locally advanced ESCC from 2006 to 2014. All of them were treated with radio-chemotherapy followed by esophagectomy. The resection specimens were evaluated microscopically for percentage of viable residual tumor comparing with tumor bed, number of positive lymph nodes and, consequently, assigned TRG grade according to each TRG system. Kaplan-Meier (KM) graphs were used to describe the median survival time. Log-rank tests and cox proportional hazard regression models were used in assessing associations between TRG systems and survival. Proportional hazard assumptions were evaluated on the basis of Schoenfeld and log-log plot. Akaike information criterion (AIC) values and pseudo R-squared values assessed model fit. All statistical tests were two-sided.
RESULTS: The KM graphs displayed overlapped curves in all TRG systems. The log-rank tests revealed that Schneider, JES and Mandard systems were statistically associated with overall-survival (P<0.05). Only the multivariate cox regression analysis of Schneider system showed the statistically significant hazard ratio (P=0.037). Schneider system also had the best AIC and pseudo R-squared values.
CONCLUSIONS: Schneider system might be the best predictive system. However, the overlapped KM curve opposed. This study had limitation due to small number of participants. More participants were needed to confirm our findings.

Entities:  

Keywords:  Esophageal cancer squamous cell carcinoma; neoadjuvant therapy; prognosis

Year:  2019        PMID: 31032095      PMCID: PMC6465493          DOI: 10.21037/jgo.2018.12.01

Source DB:  PubMed          Journal:  J Gastrointest Oncol        ISSN: 2078-6891


  21 in total

1.  Posttherapy pathologic stage predicts survival in patients with esophageal carcinoma receiving preoperative chemoradiation.

Authors:  Lucian R Chirieac; Stephen G Swisher; Jaffer A Ajani; Ritsuko R Komaki; Arlene M Correa; Jeffrey S Morris; Jack A Roth; Asif Rashid; Stanley R Hamilton; Tsung-Teh Wu
Journal:  Cancer       Date:  2005-04-01       Impact factor: 6.860

2.  Effects of neoadjuvant radiochemotherapy on pathological staging and prognosis for locally advanced esophageal squamous cell carcinoma.

Authors:  X-F Cao; X-T He; L Ji; J Xiao; J Lv
Journal:  Dis Esophagus       Date:  2009       Impact factor: 3.429

3.  Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world.

Authors:  Farin Kamangar; Graça M Dores; William F Anderson
Journal:  J Clin Oncol       Date:  2006-05-10       Impact factor: 44.544

4.  Excellent interobserver agreement on grading the extent of residual carcinoma after preoperative chemoradiation in esophageal and esophagogastric junction carcinoma: a reliable predictor for patient outcome.

Authors:  Tsung-Teh Wu; Lucian R Chirieac; Susan C Abraham; Alyssa M Krasinskas; Huamin Wang; Asif Rashid; Arlene M Correa; Wayne L Hofstetter; Jaffer A Ajani; Stephen G Swisher
Journal:  Am J Surg Pathol       Date:  2007-01       Impact factor: 6.394

5.  The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence.

Authors:  Heiko Pohl; H Gilbert Welch
Journal:  J Natl Cancer Inst       Date:  2005-01-19       Impact factor: 13.506

6.  Histomorphologic tumor regression and lymph node metastases determine prognosis following neoadjuvant radiochemotherapy for esophageal cancer: implications for response classification.

Authors:  Paul M Schneider; Stephan E Baldus; Ralf Metzger; Martin Kocher; Rudolf Bongartz; Elfriede Bollschweiler; Hartmut Schaefer; Juergen Thiele; Hans P Dienes; Rolf P Mueller; Arnulf H Hoelscher
Journal:  Ann Surg       Date:  2005-11       Impact factor: 12.969

7.  Proposed revision of the esophageal cancer staging system to accommodate pathologic response (pP) following preoperative chemoradiation (CRT).

Authors:  Stephen G Swisher; Wayne Hofstetter; Tsung T Wu; Arlene M Correa; Jaffer A Ajani; Ritsuko R Komaki; Lucian Chirieac; Kelly K Hunt; Zhongxing Liao; Alexandria Phan; David C Rice; Ara A Vaporciyan; Garrett L Walsh; Jack A Roth
Journal:  Ann Surg       Date:  2005-05       Impact factor: 12.969

8.  Histomorphological tumor regression grading of esophageal carcinoma after neoadjuvant radiochemotherapy: which score to use?

Authors:  R M Hermann; O Horstmann; F Haller; C Perske; H Christiansen; A Hille; H Schmidberger; L Füzesi
Journal:  Dis Esophagus       Date:  2006       Impact factor: 3.429

9.  Pathological analysis after neoadjuvant chemoradiotherapy for esophageal carcinoma: the Rotterdam experience.

Authors:  E van Meerten; A van der Gaast; H W Tilanus; J W Poley; K Muller; H van Dekken
Journal:  J Surg Oncol       Date:  2009-07-01       Impact factor: 3.454

Review 10.  Environmental causes of esophageal cancer.

Authors:  Farin Kamangar; Wong-Ho Chow; Christian C Abnet; Sanford M Dawsey
Journal:  Gastroenterol Clin North Am       Date:  2009-03       Impact factor: 3.806

View more
  3 in total

1.  Prognostic and predictive values of interim 18F-FDG PET during neoadjuvant chemoradiotherapy for esophageal cancer: a systematic review and meta-analysis.

Authors:  Sangwon Han; Yong-Il Kim; Sungmin Woo; Tae-Hyung Kim; Jin-Sook Ryu
Journal:  Ann Nucl Med       Date:  2021-01-20       Impact factor: 2.668

2.  18F-FDG PET/CT Metrics Are Correlated to the Pathological Response in Esophageal Cancer Patients Treated With Induction Chemotherapy Followed by Neoadjuvant Chemo-Radiotherapy.

Authors:  Nicola Simoni; Gabriella Rossi; Giulio Benetti; Michele Zuffante; Renato Micera; Michele Pavarana; Stefania Guariglia; Emanuele Zivelonghi; Valentina Mengardo; Jacopo Weindelmayer; Simone Giacopuzzi; Giovanni de Manzoni; Carlo Cavedon; Renzo Mazzarotto
Journal:  Front Oncol       Date:  2020-11-27       Impact factor: 6.244

3.  Shrinkage versus fragmentation response in neoadjuvantly treated oesophageal adenocarcinoma: significant prognostic relevance.

Authors:  Sonay Kus Öztürk; Ali Al-Kaabi; Maria J Valkema; Cristina Graham Martinez; John-Melle Bokhorst; Camiel Rosman; Heidi Rütten; Carla A P Wauters; Michail Doukas; Joseph Jan-Baptist van Lanschot; Peter D Siersema; Iris D Nagtegaal; Rachel Sofia van der Post
Journal:  Histopathology       Date:  2022-04-06       Impact factor: 7.778

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.